Research
ESMO Congress
The most influential oncology platform in Europe, showcasing groundbreaking clinical trials and cancer research.
- When
- September, Mid September
- Where
- RotatingView on Google Maps
- Format
- Hybrid
- Organiser
- European Society for Medical Oncology
- Region
- Global
- Scale
- About 30,000 attendees
- Founded
- 1975
The briefing
The ESMO Congress is a massive international meeting dedicated to clinical oncology. Organized by the European Society for Medical Oncology, the congress is where major clinical trial results for cancer therapeutics and diagnostics are presented. In recent years, it has increasingly featured digital oncology, precision medicine algorithms, and AI imaging tools. For life science investors and biotech operators, it is a critical milestone event where positive clinical data can reshape market valuations.
What to expect
- Late breaking phase III oncology clinical trial results
- Updates on companion diagnostics and biomarker technologies
- Presentations of AI tools for cancer staging and pathology
Who is in the room
Oncologists, clinical trial investigators, pharmaceutical executives, life science analysts, and biotech investors.
Background
ESMO began as a professional society in 1975 and its annual congress has grown to be a premier venue for oncology science globally. It competes directly with the US based ASCO meeting in scientific importance.
Related events
Running this event, or spotted something out of date?